Atlas Trials

Safety and Efficacy of Brexpiprazole in the Treatment of Schizophrenia

Clinical trial NCT03874494 · COMPLETED

Trial details

NCT number
NCT03874494
Sponsor
Otsuka Beijing Research Institute
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Schizophrenia
Start date
2019-11-27
Primary completion
2021-08-06
Enrollment
371

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.